China Pharma Holdings (CPHI) Shares Outstanding (2011 - 2026)

China Pharma Holdings' Shares Outstanding (Entity) history runs 14 years deep, the most recent figure standing at $338357.0 for Q4 2023.

• Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $338357.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $338357.0 (changed N/A YoY) and the FY2023 annual result came in at $338357.0, changed N/A from the prior year.
• Shares Outstanding (Entity) was $338357.0 for Q4 2023 at China Pharma Holdings, up from $264327.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $338357.0 in Q4 2023 and bottomed at $87159.0 in Q1 2019.
• A 5-year average of $135195.0 and a median of $94679.0 in 2021 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2019 — Shares Outstanding (Entity) changed 0.0% — and 2023, when it jumped 74.95%.
• China Pharma Holdings' Shares Outstanding (Entity) stood at $87159.0 in 2019, then changed by 0.0% to $87159.0 in 2020, then advanced by 8.63% to $94679.0 in 2021, then rose by 4.16% to $98620.0 in 2022, then jumped by 243.09% to $338357.0 in 2023.
• Business Quant data shows CPHI's Shares Outstanding (Entity) at $338357.0 in Q4 2023, $264327.0 in Q3 2023, and $168999.0 in Q2 2023.